Şifa Karahan
Şifa Karahan has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Armagan Erdem Utuk
Çukurova University
2 shared publications - Funda Eşki
Çukurova University
2 shared publications - Hatice Yazgan
Department of Food Hygiene and Technology, Faculty of Ceyhan Veterinary Medicine, Cukurova University, Adana 01250, Türkiye
2 shared publications - İbRahim Kivrak
Muğla Sıtkı Koçman University, Muğla Vocational School, Department of Chemistry and Chemical Treatment Technologies, Muğla, Türkiye
2 shared publications - Nevin Turut
Adana Veterinary Control Institute
2 shared publications - Osman Sezer
T.C Ministry of Agriculture and Forestry, Adana Veterinary Control Institute
2 shared publications
Latest Publications
- Open Access
- 17 December 2023
- Published by AOSIS in Onderstepoort Journal of Veterinary Research
- Vol. 91 (1) , 6-e6
A potential antifungal bioproduct for Microsporum canis: Bee venom
Natural treatment options for Microsporum canis dermatophytosis are being explored because of resistance to several antifungal medications. In this study, the potential antifungal effect of bee venom (BV), a natural antimicrobial agent, on M. canis was investigated. The antifungal effects of BV, fluconazole, itraconazole, amphotericin B and terbinafine were evaluated by the macrodilution method at various concentrations by modifying the microdilution method recommended by the European Committee on Antimicrobial Susceptibility Testing. All isolates were observed to be susceptible to terbinafine and fully resistant to fluconazole and amphotericin B. Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) values of M. canis isolate 2 (Mc2) were determined as 8 µg/mL for itraconazole. The MIC and MFC values of BV were found to be 320 µg/mL for the Mc2 isolate and 640 µg/mL for the Mc6 isolate. The results showed that the isolates obtained from clinical samples in this study were highly resistant to all antifungal agents, except terbinafine. The increase in resistance indicates that antifungal drugs will become insufficient and ineffective over time and natural products such as BV should be evaluated as alternatives. Contribution: Although there are many drugs for the treatment of M. canis, the increase in resistance to antifungal agents reveals the need for the identification and development of new natural agents. Bee venom, which has been shown to have a safe and weak allergenic effect in various studies, can be tested for usability as a local antifungal drug when supported by in vivo studies.
- 17 December 2023
- Published by AOSIS in Onderstepoort Journal of Veterinary Research
- Vol. 91 (1) , 6-e6
Open AccessA potential antifungal bioproduct for Microsporum canis: Bee venom
Natural treatment options for Microsporum canis dermatophytosis are being explored because of resistance to several antifungal medications. In this study, the potential antifungal effect of bee venom (BV), a natural antimicrobial agent, on M. canis was investigated. The antifungal effects of BV, fluconazole, itraconazole, amphotericin B and terbinafine were evaluated by the macrodilution method at various concentrations by modifying the microdilution method recommended by the European Committee on Antimicrobial Susceptibility Testing. All isolates were observed to be susceptible to terbinafine and fully resistant to fluconazole and amphotericin B. Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) values of M. canis isolate 2 (Mc2) were determined as 8 µg/mL for itraconazole. The MIC and MFC values of BV were found to be 320 µg/mL for the Mc2 isolate and 640 µg/mL for the Mc6 isolate. The results showed that the isolates obtained from clinical samples in this study were highly resistant to all antifungal agents, except terbinafine. The increase in resistance indicates that antifungal drugs will become insufficient and ineffective over time and natural products such as BV should be evaluated as alternatives. Contribution: Although there are many drugs for the treatment of M. canis, the increase in resistance to antifungal agents reveals the need for the identification and development of new natural agents. Bee venom, which has been shown to have a safe and weak allergenic effect in various studies, can be tested for usability as a local antifungal drug when supported by in vivo studies.
- Open Access
- 20 July 2023
- Published by AOSIS in Onderstepoort Journal of Veterinary Research
- Vol. 90 (1) , 5-e5
Chemical composition and antibacterial activity of bee venom against multi-drug resistant pathogens
The Onderstepoort Journal of Veterinary Research (OJVR), is the official publication of the Onderstepoort Veterinary Institute. It publishes scientific papers reporting original research on diseases and disease vectors of livestock and wildlife with a focus on Africa, but with results of more than local interest.
- 20 July 2023
- Published by AOSIS in Onderstepoort Journal of Veterinary Research
- Vol. 90 (1) , 5-e5
Open AccessChemical composition and antibacterial activity of bee venom against multi-drug resistant pathogens
The Onderstepoort Journal of Veterinary Research (OJVR), is the official publication of the Onderstepoort Veterinary Institute. It publishes scientific papers reporting original research on diseases and disease vectors of livestock and wildlife with a focus on Africa, but with results of more than local interest.